These findings suggest that LS exerts its anti-tumor effects by simultaneously enhancing ROS generation, inhibiting the PI3K/AKT/GSK-3β pathway, and restraining HepG2 cell proliferation. The gene discussed is PIK3CA; the disease is neoplasm.